D2R antagonism can provoke extrapyramidal symptoms and hyperprolactinemia, but such side effects are less common with DPAs, including the analogues aripiprazole, cariprazine, and brexpiprazole, which are partial D2R agonists.1 This evidence concerns the gene DRD2 and hyperprolactinemia.